Krishna Institute of Medical Sciences Limited
KIMS
Category
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 136.38 | 111.99% |
| 2025 | 64.33 | 21.99% |
| 2024 | 52.73 | 58.13% |
| 2023 | 33.35 | 0.97% |
| 2022 | 33.03 | -10.97% |
| 2021 | 37.10 | -40.47% |
| 2020 | 62.31 | -137.31% |
| 2019 | -167.02 | 4.63% |
| 2018 | -159.63 | -173.77% |
| 2017 | 216.38 | -17.95% |
| 2016 | 263.72 | -78.91% |
| 2015 | 1.25K | 24.75% |
| 2014 | 1.00K | 170.36% |
| 2013 | 370.73 | 0.00% |
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 15.70 | -88.49% |
US
|
|
| - | - |
DE
|
|
| 10.40 | -92.38% |
US
|
|
| 32.07 | -76.48% |
SA
|
|
| 20.00 | -85.33% |
BR
|
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.